购物车
- 全部删除
- 您的购物车当前为空
WJ-39 是一种具有口服活性的醛糖还原酶 (AR) 抑制剂,通过激活 Nrf2 信号传导来改善糖尿病肾病的肾脏病变,可用于改善肾功能不全和纤维化。WJ-39 抑制氧化应激,抑制寡聚化结构域样受体家族pyrin结构域3(NLRP3)炎症小体的激活。
为众多的药物研发团队赋能,
让新药发现更简单!
WJ-39 是一种具有口服活性的醛糖还原酶 (AR) 抑制剂,通过激活 Nrf2 信号传导来改善糖尿病肾病的肾脏病变,可用于改善肾功能不全和纤维化。WJ-39 抑制氧化应激,抑制寡聚化结构域样受体家族pyrin结构域3(NLRP3)炎症小体的激活。
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
1 mg | ¥ 1,160 | 现货 | |
5 mg | ¥ 2,880 | 现货 | |
10 mg | ¥ 4,630 | 现货 | |
25 mg | ¥ 7,150 | 现货 | |
50 mg | ¥ 9,630 | 现货 | |
100 mg | ¥ 12,900 | 现货 |
产品描述 | WJ-39 is an orally active aldose reductase (AR) inhibitor that ameliorates renal lesions in diabetic nephropathy through activation of Nrf2 signaling, and may be used to ameliorate renal insufficiency and fibrosis.WJ-39 inhibits oxidative stress and inhibits the activation of the inflammatory vesicle of the oligomerization structural domain-like receptor family, pyrin structural domain 3 (NLRP3). |
别名 | WJ39, WJ 39 |
分子量 | 430.32 |
分子式 | C19H14Cl2KNO4 |
CAS No. | 3009908-95-3 |
Smiles | O=C(CN1C=C(CC2=C(Cl)C(Cl)=CC=C2)C(C3=CC(OC)=CC=C31)=O)[O-].[K+] |
密度 | no data available |
存储 | store at low temperature | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. | |||||||||||||||||||||||||||||||||||
溶解度信息 | DMSO: 100 mg/mL (232.39 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
溶液配制表 | ||||||||||||||||||||||||||||||||||||
DMSO
|
版权所有©2015-2024 TargetMol Chemicals Inc.保留所有权利.
评论内容